Abstracts

PQBP1 Is a Retrovirus-Specific Sensor Mediating cGAS/IRF3-Dependent Innate Responses

Background: Infection of dendritic cells (DCs) by HIV-1 triggers an innate immune response that has been shown to be mediated through a cyclic GAMP synthase (cGAS)/IRF3- dependent pathway. We hypothesized that this pathway was activated by a cellular factor that recognizes a retrovirus-encoded molecular feature upstream of cGAS/IRF3. In an attempt to identify this proximal…

Mucosal HIV-1 Transmission Specifically Selects for Type 1 Interferon-Resistant Viruses

Background: Mucosally transmitted founder (TF) HIV-1 are more resistant to the antiviral effects of type 1 interferons (IFNs) than viruses that predominate during chronic infection. To determine whether IFN-resistant viruses are specifically selected for during HIV-1 transmission, we derived viral isolates by limiting dilution from both plasma and genital fluids of chronically infected transmission donors…

Inflammation Persists Despite Early Initiation of ART in Acute HIV Infection

Background: Biomarkers of microbial translocation, inflammation, coagulation and fibrosis predict morbidity and mortality in patients with chronic HIV infection. The effects of starting antiretroviral therapy (ART) in patients with acute HIV infection (AHI) on levels of these biomarkers in chronic treated infection are unknown and may illuminate the potential impact of early ART on clinical…

Identification and Characterization of Individual HIV-Infected CD4 T Cells Ex Vivo

Background: Identification of live HIV-infected CD4 cells would allow the characterization of these cells by flow cytometry and single cell transcriptomic analysis. Methods: bnAbs were screened for their ability to identify individual BaL-infected primary CD4 T cells as identified by P24 intracellular staining and transcription of Gag, and D1A3 (Tat-associated) and D1A4b (Rev-associated) spliced HIV…

Efficacy of HIV-1 Monoclonal Antibody Immunotherapy in Acute SHIV-Infected Macaques

Background: Highly potent broadly neutralizing HIV-1 antibodies (bNAb) can suppress viremia in both humanized mouse and macaque models of HIV-1 infection. However, the therapeutic potential of these antibodies during early acute infection (e.g. Fiebig I-III) is unknown. Recent clinical evidence indicates that antiretroviral therapy (ART) administered during this period suppresses both viremia and seeding of…

Impact of Systemic Cytotoxic Chemotherapy for Malignancies on HIV-1 Reservoir Persistence

Background: The effects of cytotoxic chemotherapeutic agents on viral reservoir size are not well understood. Therefore, we studied the longitudinal effect of combination chemotherapy for hematologic malignancies and single-agent chemotherapy for Kaposi Sarcoma (KS) on HIV-1 reservoir size. Methodology: HIV-infected individuals with a diagnosis of malignancy, including hematologic malignancies, KS and Multicentric Castleman’s Disease (MCD)…

Dynamics of HSPC Repopulation in Non-human Primates Revealed by a Decade-long Clonal Tracking

Background: Hematopoietic stem cell and progenitor cell (HSPC)-based genetic therapy to treat HIV or other previously incurable diseases is becoming increasingly realistic. To date, however, our understanding of the regenerative potentials of primate HSPCs lags far behind the level desired for current and future uses of these cells for therapeutic purposes. Methodology: We report detailed…